Phase 4 N=88 Comparison of Metoprolol and Tramadol With Remifentanil in Endoscopic Sinus Surgery
Nasal Polyps
Primary: Intraoperative Bleeding Score — 1; 1 units on a scale — p=>0.69
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=116 Does Deep Neuromuscular Blockade Improve Operating Conditions During Total Hip Replacements?
Arthropathy of Hip
Primary: Surgical Conditions — 1; 2; 11; 10 Participants
Phase 4 N=16 Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage
Aneurysmal Subarachnoid Hemorrhage
Primary: Average Numeric Pain Score — 5.2; 5.8 score on a scale — p=0.7
Phase 4 N=21 Phenytoin for Memory Impairment Secondary to Megestrol
Cognitive Impairment
Primary: Rey Auditory Verbal Learning Test (RAVLT) — 51.89; 45.90; 48.37 T-scores — p=0.003
Phase 4 N=206 Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia
Hypercholesterolemia · Acute Coronary Syndrome
Primary: Percent Change From Baseline in Normalized Total Atheroma Volume (TAV) at Week 36 — -3.14; -4.79 percent change — p=0.2279
Phase 4 N=222 The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy
Hepatic Encephalopathy · Cirrhosis
Primary: Number of Participants Reporting a First Breakthrough HE Episode — 28; 15 Participants — p=0.0359
Phase 4 N=498 Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery
Anticoagulation
Primary: Number of Participants With Composite of International Society on Thrombosis and Haemostasis (ISTH) Major Bleeding/Clinically Relevant Non-major Bleeding (CRNM) While…
Phase 4 N=97 Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery
Bleeding · Surgical Blood Loss
Primary: Median Volume of Mediastinal Fluid Collected From Participants — 500; 540 mL
Phase 4 N=20 Alirocumab in Patients With Acute Myocardial Infarction
Myocardial Infarction · Hypercholesterolemia
Primary: Changes in Low-density Lipoprotein (LDL) Cholesterol — -73; 2 percent change — p=<0.01
Phase 4 N=178 Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Primary: Change From Baseline in HbA1c — 0.05; -0.61 % (value of HbA1c) — p=<0.001
Phase 4 N=21 Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%
Actinic Keratosis
Primary: Change in Lesion Count From Baseline to Day 59 — 2.7 Leasion Count
Phase 4 N=100 Pain Management in Response to Exparel vs. Standard Bupivicaine
Pain
Primary: Overall Amounts of Pain Medications Consumed Through Post-operative Day 7 — 1294; 1455.5 tablets
Phase 4 N=284 Uterotonic Prophylaxis Trial
Hemorrhage
Primary: Number of Participants With Excessive Bleeding as Determined by the Composite Outcome Criteria — 78; 75 Participants — p=0.5
Phase 4 N=53 An Efficacy and Safety Study Evaluating Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face
Aged Skin
Primary: Percentage of Improved Participants on the Global Aesthetic Improvement Scale (GAIS)-Subject — 91.7; 80.0; 79.2; 72.0 % improved participants
Phase 4 N=80 Effect of Ketamine on Analgesia Post-Cardiac Surgery
Pain, Postoperative
Primary: Quantity of Opioids Used in the First 48 Hours Postoperatively — 10.71; 11.14 mg of Dilaudid